Woman & Doctor

ENCLEAR THERAPIES

Our mission is to improve and extend the lives of patients suffering from central nervous system (CNS) disorders such as neurodegenerative diseases and CNS malignancies.

 

NEURO SPECIALTY PHARMA

We are building an integrated neuro specialty pharma business using our CSF Health Platform to create a pipeline of significant near-term commercial opportunities. Launching into neuro-oncology, while leveraging business development to expand our portfolio into neurodegenerative, lysosomal storage & autoimmune diseases.

 
Doctor Holding Patient's Hand

ABOUT ENCLEAR

Our mission is to improve and extend the lives of patients suffering from central nervous system (CNS) disorders such as neurodegenerative diseases and CNS malignancies.

Our opportunity is to utilize Closed loop CSF control & integrated ML/A to provide Patient Optimized Dosing (POD) to areas of the CNS most benefited by both existing & next-generation therapeutics.

Our strategy is two-fold:

1) Launch into neuro oncology, immediately addressing $1.2B market need. 

2) Leverage business development to expand portfolio, with next gen personalized medicine, into neurodegenerative, lysosomal storage & autoimmune diseases.

 

CSF HEALTH PLATFORM

Closed loop CSF control & integrated ML/AI, the EnClear Therapies CSF health platform provides Patient Optimized Dosing (POD) of CNS based therapeutics to obtain efficacious levels, while reducing risk of severe side effects and peripheral toxicity.

Brain Scans